car-t for myeloma: where are we now and where are we going?
Published 2 years ago • 160 plays • Length 5:15Download video MP4
Download video MP3
Similar videos
-
0:48
selecting patients with multiple myeloma for car-t therapy
-
3:27
car t-cells for mm: where are we going?
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
2:01
car-t updates in myeloma
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
5:46
where in the treatment sequence should car t-cells be used for myeloma?
-
2:37
moving forwards with car t-cells in myeloma
-
4:23
what are car-t cells? how are they made?
-
2:21
car t-cell therapy: how does it work?
-
5:19
a 17-year fight against multiple myeloma
-
1:06
moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
-
7:36
car-t for myeloma: the show must go on
-
3:27
car-t cells in myeloma
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:18
moving forward: bringing car-t therapy to a frontline setting in myeloma
-
8:11
current car-t climate in multiple myeloma
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
2:13
car t-cells for mulitple myeloma
-
2:14
future role of car-t in myeloma